Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India

Eur Respir J. 2017 Mar 22;49(3):1601699. doi: 10.1183/13993003.01699-2016. Print 2017 Mar.

Authors

Zarir F Udwadia¹, Shashank Ganatra¹, Jai B Mullerpattan²

Affiliations

¹ Dept of Respiratory Medicine, P.D. Hinduja National Hospital and Medical Research Center, Mumbai, India.
² Dept of Respiratory Medicine, P.D. Hinduja National Hospital and Medical Research Center, Mumbai, India jaimuller@hotmail.com.

PMID: 28331036
DOI: 10.1183/13993003.01699-2016

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Antitubercular Agents / administration & dosage*
Compassionate Use Trials
Diarylquinolines / administration & dosage*
Female
Humans
India
Male
Mycobacterium tuberculosis / isolation & purification
Tuberculosis, Multidrug-Resistant / drug therapy*
Young Adult

Substances

Antitubercular Agents
Diarylquinolines
bedaquiline